Los Angeles Allergist

Los Angeles Allergist

Alan Khadavi, MD, APC
  • Home
  • Meet Dr. Khadavi
  • Conditions We Treat
  • Your First Visit
  • Insurance Accepted
  • Allergy and Asthma Info
    • Asthma Info
    • Allergic Rhinitis
    • Allergic Triggers
  • Blog
  • Media
  • Contact Us

9001 Wilshire Blvd. Suite 204
Beverly Hills, CA 90211
Phone: 310-282-8822

15450 Ventura Blvd. Suite 102
Sherman Oaks, CA 91403
Phone: 818-528-7776

March 11, 2015 by Alan Khadavi

Toxic Mold Syndrome

There is a great deal of controversy surrounding toxic mold syndrome,  most notably how to diagnose it.  A study of 65 patients who claimed to have toxic mold syndrome reported symptoms of rhinitis, cough, headache, respiratory symptoms, central nervous system symptoms and fatigue.  The range of patients who had these symptoms was 23%-62%.  Only 53% of these patients were allergy skin reactive to a panel of fungi that were performed by an allergist.  Another study of 32  mold exposed patients using questionnaires and medical record reviews found only a few had fungal allergy, although a number of them had asthma symptoms.  Exposures were to Stachybotrys, Aspergillus and Penicillium mold.

Controversy regard toxic mold syndrome revolves around exposure to Stachybotrys charatrum, the so called toxic mold or black mold.  This mold grows on water damaged areas and is a marker for damp environments.  In animal models, it shows a change in respiratory epithelium, especially in developing lungs.  A review of this fungus in the buildings concluded that the amount of exposure to the humans was insufficient to cause significant health effects.

Fungal exposure has been the subject of much litigation and speculation often involving ill defined illness.  The Institute of Medicine issued a statement regarding damp spaces and reported health effects, “insufficient evidence to determine an association between mycotoxin (fungal) exposure and a number of other reported health effects, including gastrointestinal problems, fatigue, neuro-psychiatric symptoms and skin problems.  The World Health Organization also agreed with this conclusion.

Fungi clearly can cause clinical allergy.  Skin tests and blood tests can identify those patients that are usually performed by allergy doctor’s.  The known health effects of fungal exposure include the increased risk of developing asthma in young children.  Interventions include reducing indoor moisture, removing contaminated materials and reducing reservoirs that grow fungus.  Although there are still controversies that surround toxic mold syndrome, there has been insufficient evidence for an association between fungal exposure and adverse health effects.

Filed Under: Blog, Headlines

alan-khadavi
Dr. Alan Khadavi
Allergy & Asthma Specialist

Latest Posts

November 17, 2026

Low Dose Naltrexone for MCAS: Benefits, Risks, and Evidence

LDN for MCAS

November 13, 2026

Cardamom Allergy: Symptoms, Diagnosis, and What to Avoid

cardamom allergy

October 28, 2026

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

Dr. Alan Khadavi Recognized as Top Allergist in Southern California

October 26, 2026

Which Biologic Works Best for Nasal Polyps?

best biologic for nasal polyps

October 19, 2026

Xolair vs. Omlyclo: Cost, Effectiveness, Insurance & Switching

Xolair vs Omlyclo: Cost, Effectiveness, Insurance & Switching

October 8, 2026

Tapioca Allergy: Can Cassava Cause an Allergic Reaction?

tapioca allergy

October 8, 2026

Rhapsido for Symptomatic Dermographism: An Allergist Explains the New FDA-Approved Treatment

Rhapsido for symptomatic dermographism

October 6, 2026

Most Effective Treatments for Severe Atopic Dermatitis: New Rankings

`most-effective-treatments-severe-atopic-dermatitis

October 6, 2026

Should Airlines Be Required to Carry Epinephrine? An Allergist Explains

airline epinephrine requirement

October 2, 2026

Ketotifen for MCAS: Uses, Benefits, Side Effects, and U.S. Availability

ketotifen for MCAS

Read More Posts...

Follow Us…

© 2026 Allergy Los Angeles. All Rights Reserved · Log in · Return to top of page